P-Co-Li (Pulmonary Covid-19 Study)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2021

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
Covid19Lung InflammationHypoxemic Respiratory Failure
Interventions
OTHER

Steroid Taper (Prednisone)

The patients randomized to the steroid group will be prescribed prednisone PO or an equivalent corticosteroid at a dose of 0.5 mg/kg/day for 4 weeks ((plus BACTRIM-DS (1PO qd. 160/800mg) as prophylaxis against infection - If patient have a sulfa allergy, their physician will prescribe atovaquone 1500mg qd instead of Bactrim) and followed by a gradual taper of 0.25 mg/kg/day for 4 weeks, followed by 0.125 mg/kg qd for 4 weeks.

Trial Locations (1)

11030

Northwell Health, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER